Abstract
NF-κB plays a pivotal role in normal T-cell activation and may also mediate human T-cell leukemia virus (HTLV)-induced T-cell transformation. Activation of NF-κB by both T-cell costimulatory signals and the HTLV Tax protein involves stimulation of IκB kinase (IKK). As a genetic approach to dissect the intermediate steps involved in NF-κB activation in human T cells, we performed somatic cell mutagenesis to isolate signaling-defective mutant Jurkat T-cell lines. One of the mutant cell lines was shown to have a specific blockade in the IKK signaling pathway but remained competent in the c-Jun N-terminal kinase and MAP kinase pathways. Interestingly, this mutant cell line lacks expression of IKKγ, a non-catalytic component of the IKK complex. Expression of exogenous IKKγ in the mutant cells restored NF-κB activation by both the T-cell costimulation agents and Tax. These findings provide genetic evidence for the requirement of IKKγ in NF-κB signaling triggered by both T-cell costimulatory signals and HTLV-I Tax protein.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arima N, Molitor JA, Smith MR, Kim JH, Daitoku Y and Greene WC . 1991 J Virol 65: 6892–6899
Baldwin Jr AS . 1996 Annu Rev Immunol 14: 649–683
Ballard DW, Böhnlein E, Lowenthal JW, Wano Y, Franza BR and Greene WC . 1988 Science 241: 1652–1654
Ballard DW, Walker WH, Doerre S, Sista P, Molitor JA, Dixon EP, Peffer NJ, Hannink M and Greene WC . 1990 Cell 63: 803–814
Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY and Ballard DA . 1995 Mol Cell Biol 15: 2809–2818
Brown K, Gerstberger S, Carlson L, Franzoso G and Siebenlist U . 1995 Science 267: 1485–1488
Bryan RG, Li Y, Lai J-H, Van M, Rice NR, Rich RR and Tan T-H . 1994 Mol Cell Biol 14: 7933–7942
Chen Z, Hagler J, Palombella V, Melandri F, Scherer D, Ballard D and Maniatis T . 1995 Genes Dev 9: 1586–1597
Chiao PJ, Miyamoto S and Verma IM . 1994 Proc Natl Acad Sci USA 91: 28–32
Chu Z-L, Shin Y-A, Yang J-M, DiDonato JA and Ballard DW . 1999 J Biol Chem 274: 15297–15300
Courtois G, Whiteside ST, Sibley CH and Israel A . 1997 Mol Cell Biol 17: 1441–1449
de Martin R, Vonhove B, Cheng Q, Hofer E, Csizmadia V, Winkler H and Bach FH . 1993 EMBO J 12: 2773–2779
DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E and Karin M . 1997 Nature 388: 548–554
Ganchi PA, Sun S-C, Greene WC and Ballard DW . 1992 Mol Biol Cell 3: 1339–1352
Geleziunas R, Ferrell S, Lin X, Mu Y, Cunningham Jr ET, Grant M, Connelly MA, Hambor JE, Marcu KB and Greene WC . 1998 Mol Cell Biol 18: 5157–5165
Gerondakis S, Grumont R, Rourke I and Grossmann M . 1998 Curr Opin Immunol 10: 353–359
Ghosh P, Tan T-H, Rice NR, Sica A and Young HA . 1993 Proc Natl Acad Sci USA 90: 1696–1700
Ghosh S, May MJ and Kopp EB . 1998 Annu Rev Immunol 16: 225–260
Good L and Sun S-C . 1996 J Virol 70: 2730–2735
Harhaj EW, Maggirwar SB, Good L and Sun S-C . 1996 Mol Cell Biol 16: 6736–6743
Harhaj EW and Sun S-C . 1998 J Biol Chem 273: 25185–25190
Harhaj EW and Sun S-C . 1999 J Biol Chem 274: 22911–22914
Holbrook N, Gulino A and Ruscetti F . 1987 Virology 157: 211–219
Jin D-Y, Giordano V, Kibler KV, Nakano H and Jeang K-T . 1999 J Biol Chem 274: 17402–17405
Lacoste J, Petropoulos L, Pépin N and Hiscott J . 1995 J Virol 69: 564–569
Lai J-H and Tan T-H . 1994 J Biol Chem 269: 30077–30080
LeBail O, Schmidt-Ullrich R and Israël A . 1993 EMBO J 12: 5043–5049
Lee FS, Peters RT, Dang LC and Maniatis T . 1998 Proc, Natl Acad Sci USA 95: 9319–9324
Leung K and Nabel GJ . 1988 Nature 333: 776–778
Li Y, Kang J, Friedman J, Tarassishin L, Ye J, Kovalenko A, Wallach D and Horwitz MS . 1999 Proc Natl Acad Sci USA 96: 1042–1047
Ling L, Cao Z and Goeddel DV . 1998 Proc Natl Acad Sci USA 95: 3792–3797
McKendry R, John J, Flavell D, Müller M, Kerr IM and Stark GR . 1991 Proc Natl Acad Sci USA 88: 11455–11459
McKinsey TA, Brockman JA, Scherer DC, Al-Murrani SW, Green PL and Ballard WB . 1996 Mol Cell Biol 16: 2083–2090
Mercurio F, Murray BW, Shevchenko A, Bennett BL, Young DB, Li JW, Pascual G, Motiwala A, Zhu H, Mann M and Manning AM . 1999 Mol Cell Biol 19: 1526–1538
Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li JW, Young DB, Barbose M, Mann M, Manning A and Rao A . 1997 Science 278: 860–865
Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H and Okumura K . 1998 Proc Natl Acad Sci USA 95: 3537–3542
Naviaux RN, Costanzi E, Haas M and Verma IM . 1996 J Virol 70: 5701–5705
Nemoto S, DiDonato JA and Lin A . 1998 Mol Cell Biol 18: 7336–7343
Regnier CH, Song HY, Cao Z and Rothe M . 1997 Cell 90: 373–383
Ressler S, Connor LM and Marriott SJ . 1996 FEBS Microbiol Lett 140: 99–109
Rothwarf DM and Karin M . 1999 Science STKE 1999: 1–19
Rothwarf DM, Zandi E, Natoli G and Karin M . 1998 Nature 17: 297–300
Ruben S, Poteat H, Tan TH, Kawakami K, Roeder R, Haseltine W and Rosen CA . 1988 Science 241: 89–91
Schreiber E, Matthias P, Muller MM and Schaffner W . 1989 Nucl Acids Res 17: 6419
Scott ML, Fujita T, Liou H-C, Nolan GP and Baltimore D . 1993 Genes Dev 7: 1266–1276
Smith MR and Greene WC . 1991 J Clin Invest 87: 761–766
Sun S-C, Elwood J, Béraud C and Greene WC . 1994 Mol Cell Biol 14: 7377–7384
Sun S-C, Elwood J and Greene WC . 1996 Mol Cell Biol 16: 1058–1065
Sun S-C, Ganchi PA, Ballard DW and Greene WC . 1993 Science 259: 1912–1915
Sun S-C, Maggirwar SB and Harhaj E . 1995 J Biol Chem 270: 18347–18351
Sun S-C and Ballard DW . 1999 Oncogene 18: 6948–6958
Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P and Ghosh S . 1995 Cell 80: 573–582
Ting AT, Pimentel-Muinos FX and Seed B . 1996 EMBO J 15: 6189–6196
Uhlik M, Good L, Xiao G, Harhaj EW, Zandi E, Karin M and Sun S-C . 1998 J Biol Chem 273: 21132–21136
Woronicz JD, Gao X, Cao Z, Rothe M and Goeddel DV . 1997 Science 278: 866–869
Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ and Israel A . 1998 Cell 93: 1231–1240
Yin M-J, Christerson LB, Yamamoto Y, Kwak Y-T, Xu S, Mercurio F, Barbose M, Cobb MH and Gaynor RB . 1998 Cell 93: 875–884
Zandi E and Karin M . 1999 Mol Cell Biol 19: 4547–4551
Zandi E, Rothwarf DM, Delhase M, Hayakawa M and Karin M . 1997 Cell 91: 243–252
Acknowledgements
We greatly acknowledge Drs B Seed and I Verma and The Fred Hutchinson Cancer Research Center for reagents. This study was supported by Public Health Service grants 1 R01 CA68471.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harhaj, E., Good, L., Xiao, G. et al. Somatic mutagenesis studies of NF-κB signaling in human T cells: evidence for an essential role of IKKγ in NF-κB activation by T-cell costimulatory signals and HTLV-I Tax protein. Oncogene 19, 1448–1456 (2000). https://doi.org/10.1038/sj.onc.1203445
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203445
Keywords
This article is cited by
-
Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
Nature Communications (2015)
-
Modulation of NF-κB signalling by microbial pathogens
Nature Reviews Microbiology (2011)
-
NEMO specifically recognizes K63-linked poly-ubiquitin chains through a new bipartite ubiquitin-binding domain
The EMBO Journal (2009)
-
A nuclear role for Kaposi's sarcoma-associated herpesvirus-encoded K13 protein in gene regulation
Oncogene (2008)
-
Inhibition of the NF-κB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-κB essential modulator NEMO
Cell Death & Differentiation (2008)